Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Extended Interferon-Alpha Therapy Accelerates Telomere Length Loss in Human Peripheral Blood T Lymphocytes
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e20922
Publisher
Public Library of Science (PLoS)
Online
2011-08-05
DOI
10.1371/journal.pone.0020922
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Excess mortality in patients with advanced chronic hepatitis C treated with long-term peginterferon
- (2011) Adrian M. Di Bisceglie et al. HEPATOLOGY
- Reduction of Insulin Resistance With Effective Clearance of Hepatitis C Infection: Results From the HALT-C Trial
- (2010) Aymin Delgado–Borrego et al. Clinical Gastroenterology and Hepatology
- CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection
- (2010) Matthew Hoare et al. JOURNAL OF HEPATOLOGY
- Telomere Length Trajectory and Its Determinants in Persons with Coronary Artery Disease: Longitudinal Findings from the Heart and Soul Study
- (2010) Ramin Farzaneh-Far et al. PLoS One
- Association of shorter mean telomere length with risk of incident myocardial infarction: A prospective, nested case–control approach
- (2009) Robert Y.L. Zee et al. CLINICA CHIMICA ACTA
- Homeostatic proliferation and survival of naïve and memory T cells
- (2009) Onur Boyman et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The emerging role of telomere biology in cardiovascular disease
- (2009) Jardi Huzen Frontiers in Bioscience-Landmark
- Weight-Related Effects on Disease Progression in the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis Trial
- (2009) James E. Everhart et al. GASTROENTEROLOGY
- Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial
- (2009) James E. Everhart et al. HEPATOLOGY
- Weight Loss in Obese Men Is Associated with Increased Telomere Length and Decreased Abasic Sites in Rectal Mucosa
- (2009) Nathan J. O'Callaghan et al. REJUVENATION RESEARCH
- Telomere length and obesity
- (2008) Raffaella Zannolli et al. ACTA PAEDIATRICA
- Practical guidelines for the management of interferon-α-2b side effects in patients receiving adjuvant treatment for melanoma
- (2008) Axel Hauschild et al. CANCER
- Interferon-β1bfor the treatment of multiple sclerosis
- (2008) Sum Lam et al. Expert Opinion on Drug Metabolism & Toxicology
- Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
- (2008) Anna S. Lok et al. GASTROENTEROLOGY
- Incidence of Neutropenia and Infections During Combination Treatment of Chronic Hepatitis C with Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin
- (2008) M. G. Antonini et al. INFECTION
- Adipose-immune interactions during obesity and caloric restriction: reciprocal mechanisms regulating immunity and health span
- (2008) Vishwa Deep Dixit JOURNAL OF LEUKOCYTE BIOLOGY
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
- (2008) Adrian M. Di Bisceglie et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telomeres and Aging
- (2008) Geraldine Aubert et al. PHYSIOLOGICAL REVIEWS
- Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people
- (2008) Sven Koch et al. Immunity & Ageing
- Factors impacting human telomere homeostasis and age-related disease
- (2007) David Gilley et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Telomere and adaptive immunity
- (2007) Nan-ping Weng MECHANISMS OF AGEING AND DEVELOPMENT
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started